Fig. 1.
Overview of the study. CTX = crosslaps measurement; Dmab = denosumab. T0: denosumab initiation; T1: last 60 mg denosumab injection; T2: 6 months after; the 15 mg injection of denosumab; T3: 12 months after the 15 mg injection of denosumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.